HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sousa, M. M. Articles by Saraiva, M. J. Search for Related Content PubMed PubMed Citation Articles by Sousa, M. M. Articles by Saraiva, M. J. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 41, 58-65, January 2000
Copyright © 2000 by Lipid Research, Inc.

Original Article

Transthyretin in high density lipoproteins: association with apolipoprotein A-I

Correspondence to: Maria João Saraiva

Previous studies have revealed the presence of transthyretin (TTR) on lipoproteins. To further address this issue, we fractionated plasma lipoproteins from 9 normal individuals, 10 familial amyloidotic polyneuropathy (FAP) patients, and 19 hyperlipidemic subjects using gel filtration. In the majority of the subjects, as well as in 9 of the 10 FAP patients and 14 of the 19 patients with hyperlipidemia, TTR was detected by ELISA in the high density lipoprotein (HDL) fraction. The presence of TTR in HDL was confirmed by direct sequencing and by immunoblotting; using non-reducing conditions, TTR was found by immunoblotting in a high molecular weight complex, which reacted also for apolipoprotein A-I (apoA-I). The amount of TTR present in HDL (HDL-TTR), as quantified by ELISA corresponded to 1;–2% of total plasma TTR. However, no detectable TTR levels were found in HDL fraction from 6 of the hyperlipidemic subjects. No correlation was found between the lack of TTR in HDL and plasma levels of total, LDL-, or HDL-associated cholesterol as well as levels of apoA-I and total plasma TTR. Ligand binding experiments showed that radiolabeled TTR binds to the HDL fraction of individuals with HDL-TTR but not to the corresponding fractions of individuals devoid of HDL-TTR, suggesting that HDL composition may interfere with TTR binding. The component(s) to which TTR binds in the HDL fraction were investigated.

Polyclonal antibody against apoA-I was able to block the interaction of TTR with HDL, suggesting that the interaction of TTR with the HDL particle occurs via apoA-I. This hypothesis was further demonstrated by showing the formation of a complex of TTR with HDL and apoA-I by crosslinking experiments. Furthermore, anti-apoA-I immunoblot under native conditions suggested the existence of differences in HDL particle properties and/or stability between individuals with and without HDL-TTR.—Sousa, M. M., L. Berglund, and M. J. Saraiva. Transthyretin in high density lipoproteins: association with apolipoprotein A-I. J. Lipid Res. 2000. 41: 58;–65.

Supplementary key words: amyloidosis, high density lipoproteins, transthyretin, apolipoprotein A-I

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. A. Liz, C. M. Gomes, M. J. Saraiva, and M. M. Sousa ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity J. Lipid Res., November 1, 2007; 48(11): 2385 - 2395. [Abstract] [Full Text] [PDF]

				L. M. Wilson, C. L. L. Pham, A. J. Jenkins, J. D. Wade, A. F. Hill, M. A. Perugini, and G. J. Howlett High density lipoproteins bind A{beta} and apolipoprotein C-II amyloid fibrils J. Lipid Res., April 1, 2006; 47(4): 755 - 760. [Abstract] [Full Text] [PDF]

				E. Refai, N. Dekki, S.-N. Yang, G. Imreh, O. Cabrera, L. Yu, G. Yang, S. Norgren, S. M. Rossner, L. Inverardi, et al. Transthyretin constitutes a functional component in pancreatic {beta}-cell stimulus-secretion coupling PNAS, November 22, 2005; 102(47): 17020 - 17025. [Abstract] [Full Text] [PDF]

				M. K. O'Bryan, L. M. Foulds, J. F. Cannon, W. R. Winnall, J. A. Muir, K. Sebire, A. I. Smith, H.-H. Keah, M. T. W. Hearn, D. M. de Kretser, et al. Identification of a Novel Apolipoprotein, ApoN, in Ovarian Follicular Fluid Endocrinology, November 1, 2004; 145(11): 5231 - 5242. [Abstract] [Full Text] [PDF]

				C Torricelli, E Capurro, A Santucci, A Paffetti, C D'Ambrosio, A Scaloni, E Maioli, and A Pacini Multiple plasma proteins control atrial natriuretic peptide (ANP) aggregation J. Mol. Endocrinol., October 1, 2004; 33(2): 335 - 341. [Abstract] [Full Text] [PDF]

				M. A. Liz, C. J. Faro, M. J. Saraiva, and M. M. Sousa Transthyretin, a New Cryptic Protease J. Biol. Chem., May 14, 2004; 279(20): 21431 - 21438. [Abstract] [Full Text] [PDF]

				M. M. Sousa, R. Fernandes, J. A. Palha, A. Taboada, P. Vieira, and M. J. Saraiva Evidence for Early Cytotoxic Aggregates in Transgenic Mice for Human Transthyretin Leu55Pro Am. J. Pathol., November 1, 2002; 161(5): 1935 - 1948. [Abstract] [Full Text] [PDF]

				M. M. de Sousa, C. Vital, D. Ostler, R. Fernandes, J. Pouget-Abadie, D. Carles, and M. J. Saraiva Apolipoprotein AI and Transthyretin as Components of Amyloid Fibrils in a Kindred with apoAI Leu178His Amyloidosis Am. J. Pathol., June 1, 2000; 156(6): 1911 - 1917. [Abstract] [Full Text] [PDF]

				M. M. Sousa and M. J. Saraiva Internalization of Transthyretin. EVIDENCE OF A NOVEL YET UNIDENTIFIED RECEPTOR-ASSOCIATED PROTEIN (RAP)-SENSITIVE RECEPTOR J. Biol. Chem., April 20, 2001; 276(17): 14420 - 14425. [Abstract] [Full Text] [PDF]